Veterinary Services Market (By Service Type: Diagnostic tests and imaging, Physical health monitoring, Surgery, Others; By Animal Type: Production, Companion) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Veterinary Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Veterinary Services Market, by Service Type, 2024-2033
8.1.1. Diagnostic tests and imaging
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Physical health monitoring
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Surgery
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Dessert
8.1.5.1. Market Revenue and Forecast (2021-2033)
9.1. Veterinary Services Market, by Animal Type, 2024-2033
9.1.1. Production
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Poultry
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Swine
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Cattle
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Sheep & Goats
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Fish
9.1.6.1. Market Revenue and Forecast (2021-2033)
9.1.7. Companion
9.1.7.1. Market Revenue and Forecast (2021-2033)
9.1.8. Dogs
9.1.8.1. Market Revenue and Forecast (2021-2033)
9.1.9. Cats
9.1.9.1. Market Revenue and Forecast (2021-2033)
9.1.10. Horses
9.1.10.1. Market Revenue and Forecast (2021-2033)
9.1.11. Others
9.1.11.1. Market Revenue and Forecast (2021-2033)
10.1. North America
10.1.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.1.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.1.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.2.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.2.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.3.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.3.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.4.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.4.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.5.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Service Type (2021-2033)
10.5.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
11.1. Merck Animal Health
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Ceva Sante Animale
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Vetoquinol S.A.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Zoetis
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Boehringer Ingelheim GmbH
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Elanco
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Nutreco N.V.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Virbac
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Kindred Biosciences, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biogenesis Bago
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample